A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
Key Details
- 1Study presented at SNMMI evaluated a machine learning model using F-18 PSMA PET/CT imaging.
- 2Nine patients with metastatic castration-resistant prostate cancer were included, analyzing a total of 57 tumors, 36 salivary glands, and 18 kidneys.
- 3The model used uptake-based PET metrics, radiomic features, and clinical biomarkers for dose prediction.
- 4Predictions closely tracked absorbed dose values obtained from traditional post-therapy dosimetry.
- 5Using pre-therapy PET/CT data could eliminate need for additional scans and reduce patient burden.
- 6The approach is part of a larger, ongoing 5-year research program for validation.
Why It Matters
This approach suggests standard diagnostic imaging can be repurposed with AI to deliver patient-specific radiation dose estimates before therapy, potentially improving safety, efficacy, and workflow efficiency in radiopharmaceutical therapy.
Source
AuntMinnie
Related News
•AuntMinnie
AI Model Uses Ultrasound to Assess Fetal Lung Maturity
Researchers demonstrated an AI model's strong accuracy in measuring fetal lung maturity from ultrasound images.
•AuntMinnie
AI Advances in Ultrasound Highlighted at AIUM 2026 Keynote
AI is increasingly enhancing ultrasound imaging, clinical workflows, and education, though challenges in trust and implementation remain.
•AuntMinnie
LLM AI Significantly Boosts MRI Accuracy For Less Experienced Readers
AI LLMs notably improve diagnostic accuracy for less experienced brain MRI readers, with diminishing benefits for experts.